ATXS
Price
$7.50
Change
-$0.25 (-3.23%)
Updated
Jan 17 closing price
Capitalization
423.26M
47 days until earnings call
KYMR
Price
$40.61
Change
+$0.32 (+0.79%)
Updated
Jan 17 closing price
Capitalization
2.63B
33 days until earnings call
Ad is loading...

ATXS vs KYMR

Header iconATXS vs KYMR Comparison
Open Charts ATXS vs KYMRBanner chart's image
Astria Therapeutics
Price$7.50
Change-$0.25 (-3.23%)
Volume$237.44K
Capitalization423.26M
Kymera Therapeutics
Price$40.61
Change+$0.32 (+0.79%)
Volume$343.66K
Capitalization2.63B
ATXS vs KYMR Comparison Chart
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. KYMR commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Hold and KYMR is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ATXS: $7.50 vs. KYMR: $40.61)
Brand notoriety: ATXS and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 68% vs. KYMR: 68%
Market capitalization -- ATXS: $423.26M vs. KYMR: $2.63B
ATXS [@Biotechnology] is valued at $423.26M. KYMR’s [@Biotechnology] market capitalization is $2.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, ATXS is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 3 TA indicator(s) are bullish while KYMR’s TA Score has 3 bullish TA indicator(s).

  • ATXS’s TA Score: 3 bullish, 1 bearish.
  • KYMR’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than KYMR.

Price Growth

ATXS (@Biotechnology) experienced а +0.67% price change this week, while KYMR (@Biotechnology) price change was +6.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

ATXS is expected to report earnings on May 08, 2025.

KYMR is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.63B) has a higher market cap than ATXS($423M). KYMR YTD gains are higher at: 0.945 vs. ATXS (-16.107). ATXS has higher annual earnings (EBITDA): -100.97M vs. KYMR (-160.96M). KYMR has more cash in the bank: 550M vs. ATXS (344M). ATXS has less debt than KYMR: ATXS (5.64M) vs KYMR (88.2M). KYMR has higher revenues than ATXS: KYMR (87.6M) vs ATXS (0).
ATXSKYMRATXS / KYMR
Capitalization423M2.63B16%
EBITDA-100.97M-160.96M63%
Gain YTD-16.1070.945-1,705%
P/E RatioN/AN/A-
Revenue087.6M-
Total Cash344M550M63%
Total Debt5.64M88.2M6%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSKYMR
RSI
ODDS (%)
Bullish Trend 11 days ago
80%
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 11 days ago
84%
Momentum
ODDS (%)
N/A
Bearish Trend 11 days ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 11 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
86%
Bullish Trend 11 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 11 days ago
87%
Advances
ODDS (%)
Bullish Trend 17 days ago
84%
Bullish Trend 16 days ago
85%
Declines
ODDS (%)
Bearish Trend 13 days ago
89%
Bearish Trend 20 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
82%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 11 days ago
84%
View a ticker or compare two or three
Ad is loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSLCX63.640.27
+0.43%
American Funds SMALLCAP World R3
DIECX37.790.15
+0.40%
BNY Mellon International Core Equity C
JERTX11.370.01
+0.09%
Janus Henderson Global Real Estate T
DVSMX23.50N/A
N/A
Driehaus Small Cap Growth Investor
MCISX14.39N/A
N/A
Victory Trivalent International Sm-Cp C

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with KYMR. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
-3.23%
KYMR - ATXS
45%
Loosely correlated
+0.79%
IMNM - ATXS
44%
Loosely correlated
+1.32%
KALV - ATXS
44%
Loosely correlated
+0.61%
ORIC - ATXS
42%
Loosely correlated
-4.58%
ACLX - ATXS
42%
Loosely correlated
-0.79%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.79%
CCCC - KYMR
60%
Loosely correlated
+2.07%
XENE - KYMR
50%
Loosely correlated
-2.78%
ERAS - KYMR
49%
Loosely correlated
-0.54%
ACLX - KYMR
48%
Loosely correlated
-0.79%
CRSP - KYMR
48%
Loosely correlated
+0.57%
More